Submitted by Anonymous (not verified) on 9 January 2026 - 14:00
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 51, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tysabri, natalizumab, Date of authorisation: 27/06/2006, Revision: 51, Status: Authorised